Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population.
Maglalang PD, Sinha J, Zimmerman K, McCann S, Edginton A, Hornik CP, Hornik CD, Muller WJ, Al-Uzri A, Meyer M, Chen JY, Anand R, Perrin EM, Gonzalez D; Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee. Maglalang PD, et al. Among authors: muller wj. Clin Pharmacokinet. 2024 Jun;63(6):885-899. doi: 10.1007/s40262-024-01367-2. Epub 2024 May 30. Clin Pharmacokinet. 2024. PMID: 38814425
Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacy.
Maharaj AR, Wu H, Hornik CP, Arrieta A, James L, Bhatt-Mehta V, Bradley J, Muller WJ, Al-Uzri A, Downes KJ, Cohen-Wolkowiez M. Maharaj AR, et al. Among authors: muller wj. J Pharmacokinet Pharmacodyn. 2020 Jun;47(3):199-218. doi: 10.1007/s10928-020-09684-2. Epub 2020 Apr 22. J Pharmacokinet Pharmacodyn. 2020. PMID: 32323049 Free PMC article.
Pharmacokinetics of Ceftazidime in Children and Adolescents with Obesity.
Maharaj AR, Wu H, Zimmerman KO, Muller WJ, Sullivan JE, Sherwin CMT, Autmizguine J, Rathore MH, Hornik CD, Al-Uzri A, Payne EH, Benjamin DK Jr, Hornik CP; Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee. Maharaj AR, et al. Among authors: muller wj. Paediatr Drugs. 2021 Sep;23(5):499-513. doi: 10.1007/s40272-021-00460-4. Epub 2021 Jul 23. Paediatr Drugs. 2021. PMID: 34302290 Free PMC article.
Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity.
Gerhart JG, Carreño FO, Ford JL, Edginton AN, Perrin EM, Watt KM, Muller WJ, Atz AM, Al-Uzri A, Delmore P, Gonzalez D; Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee. Gerhart JG, et al. Among authors: muller wj. CPT Pharmacometrics Syst Pharmacol. 2022 Jun;11(6):778-791. doi: 10.1002/psp4.12793. Epub 2022 May 2. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35491971 Free PMC article.
Pharmacokinetics of Dexamethasone in Children and Adolescents with Obesity.
Wen J, McCann S, Balevic SJ, Muller WJ, Hornik CD, Autmizguine J, Anderson SG, Payne EH, Turdalieva S, Gonzalez D; Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee. Wen J, et al. Among authors: muller wj. J Clin Pharmacol. 2024 Aug 9. doi: 10.1002/jcph.6108. Online ahead of print. J Clin Pharmacol. 2024. PMID: 39120865
Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial.
Segers H, Deville JG, Muller WJ, Manzanares A, Desai A, Neely M, Bordon V, Hanisch B, Lassaletta A, Fisher BT, Autmizguine J, Groll AH, Sinnar S, Croos-Dabrera R, Engelhardt M, Jones M, Kovanda LL, Arrieta AC. Segers H, et al. Among authors: muller wj. Antimicrob Agents Chemother. 2024 Nov 14:e0048424. doi: 10.1128/aac.00484-24. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 39540734 Free article.
Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients.
Arrieta AC, Neely M, Day JC, Rheingold SR, Sue PK, Muller WJ, Danziger-Isakov LA, Chu J, Yildirim I, McComsey GA, Frangoul HA, Chen TK, Statler VA, Steinbach WJ, Yin DE, Hamed K, Jones ME, Lademacher C, Desai A, Micklus K, Phillips DL, Kovanda LL, Walsh TJ. Arrieta AC, et al. Among authors: muller wj. Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0029021. doi: 10.1128/AAC.00290-21. Epub 2021 Jul 16. Antimicrob Agents Chemother. 2021. PMID: 34031051 Free PMC article.
Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs.
Kociolek LK, Muller WJ, Yee R, Dien Bard J, Brown CA, Revell PA, Wardell H, Savage TJ, Jung S, Dominguez S, Parikh BA, Jerris RC, Kehl SC, Campigotto A, Bender JM, Zheng X, Muscat E, Linam M, Abuogi L, Smith C, Graff K, Hernandez-Leyva A, Williams D, Pollock NR. Kociolek LK, et al. Among authors: muller wj. J Clin Microbiol. 2020 Dec 17;59(1):e02593-20. doi: 10.1128/JCM.02593-20. Print 2020 Dec 17. J Clin Microbiol. 2020. PMID: 33093026 Free PMC article.
386 results